Skip to main content

MetLife Investment Management, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1529735 Whippany, NJ

Position in TSHA

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$536,918
-$86,045 QoQ
Shares Held
120,116
+6.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. TSHA ranks #97 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $536,918 120,116
2025-12-31 $622,963 113,266
2025-09-30 $415,433 127,044
2025-06-30 $249,660 108,078
2025-03-31 $149,718 107,711
2024-12-31 $108,972 62,990
2024-09-30 $152,834 76,037
2024-06-30 $93,618 41,794
2021-12-31 $110,779 9,509
2021-09-30 $177,057 9,509
2021-06-30 $201,590 9,509